| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 192,870 | 258,788 | 245,873 | 256,377 | | Cost of Revenue | 41,977 | 49,982 | 52,908 | 57,154 | | | Gross Profit |
-
| 208,806 | 192,965 | 199,223 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 134,922 | 122,819 | 113,104 | 110,915 | | Non Recurring | (9,257) | 5,807 | 3,450 | 192,280 | | Others | 50,176 | 122,694 | 67,464 | 235,090 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (42,514) | 8,947 | (339,062) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (24,948) | (42,514) | 8,947 | (339,062) | | Interest Expense | 16,308 | 17,895 | 20,653 | 25,427 | | Income Before Tax | (41,256) | (60,409) | (11,706) | (364,489) | | Income Tax Expense | (22,014) | (28,536) | (593) | (63,980) | | Minority Interest | (8) |
-
| (13) |
-
| | | | Net Income From Continuing Ops | (19,229) | (31,873) | (11,126) | (300,509) | | | Non-recurring Events | | Discontinued Operations |
-
| 313 |
-
| 8 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (19,250) | (31,560) | (11,126) | (300,501) | | Preferred Stock And Other Adjustments | 31,082 |
-
|
-
| (7,093) | | | Net Income Applicable To Common Shares | $11,832 | ($31,560) | ($11,126) | ($307,594) |
|
0.13% Nasdaq 
Income Statement
